Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Southeast Asian J Trop Med Public Health ; 1995 Jun; 26(2): 204-12
Article in English | IMSEAR | ID: sea-35059

ABSTRACT

An in vivo study of the response of P. falciparum to the combination drug, MSP, was conducted among gem miners who contracted malaria from Cambodia in 1991-1992. High level resistance (RII, RIII responses) was observed in 22.5% of the 40 cases attending Mae Sot malaria clinic, west Thailand border, and in 28.1% of the 96 cases attending Bo Rai malaria clinic, east Thailand border. The observations on in vitro studies conducted prior to the MSP treatment and after recrudescence, together with the findings on adequate mefloquine blood levels strongly indicated the serious deterioration of mefloquine efficacy. The first line treatment for the malaria control program needs to be revised and the use of qinghaosu derivatives considered. Intensive measures to combat spreading of the highly resistant strains to other parts of the country should be taken into account.


Subject(s)
Adult , Animals , Antimalarials/pharmacology , Cambodia , Chi-Square Distribution , Drug Combinations , Drug Resistance , Female , Humans , Malaria, Falciparum/blood , Male , Mefloquine/analogs & derivatives , Mining , Plasmodium falciparum/drug effects , Pyrimethamine/pharmacology , Sulfadoxine/pharmacology , Thailand , Transients and Migrants
2.
Southeast Asian J Trop Med Public Health ; 1995 Mar; 26(1): 38-45
Article in English | IMSEAR | ID: sea-31949

ABSTRACT

Monoclonal antibody-based ELISA and QBC (quantitative buffy coat analysis) were tested in two endemic areas with low and high incidence of malaria in Kanchanaburi Province, West Thailand with annual parasite incidence in 1992 of 119 and 5 per 1,000 population, respectively. The numbers of individuals positive by thick blood film examination (TBF) for P. falciparum with or without P. vivax, and P. vivax only were 82 and 69, respectively. The detection limit of ELISA was 10 parasites/10(6) red blood cells (RBC) (0.001% parasitemia). Of 1,095 individuals involved in the study at the beginning of the study, ELISA showed sensitivity, specificity, positive predictive value and negative predictive value of 78.1%, 94.9%, 72% and 98.1%, respectively. Nine of 18 (50%) TBF-positive but ELISA-positive individuals had parasitemia of less than 10 parasites/10(6) RBC. High and low incidence areas did not affect the validity of our result. Regression analysis showed good correlation between log parasitemia and ELISA percent OD increase (Y = 0 + 64.9*logX, r = 0.65), and agreement between TBF and ELISA results was 95.9%. In a fortnightly follow-up, in 82 TBF-positive individuals, both ELISA and TBF positive rates correlatively declined with agreement of 96.3%. With samples taken on the first day of the study, the TBF and QBC results were also correlated with agreement of 95.8% for P. falciparum, 95.6% for P. vivax. During 8 week follow-up involving altogether 191 samples, agreement between TBF and QBC results were 87.4% for P. falciparum. QBC detected more cases with P. falciparum infections but detected smaller number of cases with P. vivax infections.


Subject(s)
Animals , Antibodies, Protozoan/isolation & purification , Chi-Square Distribution , Enzyme-Linked Immunosorbent Assay , Humans , Incidence , Malaria, Falciparum/diagnosis , Malaria, Vivax/diagnosis , Parasitemia/diagnosis , Plasmodium falciparum/immunology , Plasmodium vivax/immunology , Predictive Value of Tests , Regression Analysis , Reproducibility of Results , Thailand/epidemiology , Time Factors
3.
Southeast Asian J Trop Med Public Health ; 1992 Mar; 23(1): 55-8
Article in English | IMSEAR | ID: sea-35390

ABSTRACT

With the appearance of strains of Plasmodium falciparum in the Trat Province, eastern Thailand, reported to have developed resistance to mefloquine there is a need for an alternative drug. This comparative trial with mefloquine and halofantrine has demonstrated extremely low cure rates with both drugs (33.3% and 28.13% respectively), cross-resistance is suggested.


Subject(s)
Administration, Oral , Adult , Antimalarials/administration & dosage , Drug Resistance , Female , Humans , Malaria, Falciparum/drug therapy , Male , Mefloquine/administration & dosage , Phenanthrenes/administration & dosage , Thailand/epidemiology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL